Gastroenterology
Volume 130, Issue 4 , Pages 1317-1323, April 2006

Sustained Engraftment and Tissue Enzyme Activity After Liver Cell Transplantation for Argininosuccinate Lyase Deficiency

  • Xavier Stéphenne

      Affiliations

    • Laboratoire d’hépatologie Pédiatrique et Transplantation Cellulaire, Département GYPE, Service de Pédiatrie, Université Catholique de Louvain & Cliniques St Luc, Brussels, Belgium
  • ,
  • Mustapha Najimi

      Affiliations

    • Laboratoire d’hépatologie Pédiatrique et Transplantation Cellulaire, Département GYPE, Service de Pédiatrie, Université Catholique de Louvain & Cliniques St Luc, Brussels, Belgium
  • ,
  • Catherine Sibille

      Affiliations

    • Centre de Cytogénétique, Université Catholique de Louvain & Cliniques St Luc, Brussels, Belgium
  • ,
  • Marie–Cécile Nassogne

      Affiliations

    • Service de Neurologie Pédiatrique, Université Catholique de Louvain & Cliniques St Luc, Brussels, Belgium
  • ,
  • Françoise Smets

      Affiliations

    • Laboratoire d’hépatologie Pédiatrique et Transplantation Cellulaire, Département GYPE, Service de Pédiatrie, Université Catholique de Louvain & Cliniques St Luc, Brussels, Belgium
  • ,
  • Etienne M. Sokal

      Affiliations

    • Laboratoire d’hépatologie Pédiatrique et Transplantation Cellulaire, Département GYPE, Service de Pédiatrie, Université Catholique de Louvain & Cliniques St Luc, Brussels, Belgium
    • Corresponding Author InformationAddress requests for reprints to: Etienne M. Sokal, MD, PhD, Paediatric Hepatology and Liver Transplantation, Université Catholique de Louvain, Cliniques St Luc, 10 av. Hippocrate, B-1200 Brussels, Belgium. fax: (32) 2-764-8909.

Received 7 October 2005; accepted 21 December 2005.

Background & Aims: Donor cell engraftment with expression of enzyme activity is the goal of liver cell transplantation for inborn errors of liver metabolism with a view to achieving sustained metabolic control. Methods: Sequential hepatic cell transplantations using male and female cells were performed in a 3.5-year-old girl with argininosuccinate lyase deficiency over a period of 5 months. Beside clinical, psychomotor, and metabolic follow-up, engraftment was analyzed in repeated liver biopsies (2.5, 5, 8, and 12 months after first infusion) by fluorescence in situ hybridization for the Y-chromosome and by measurement of tissue enzyme activity. Results: Metabolic control was achieved together with psychomotor catch-up, changing the clinical phenotype from a severe neonatal one to a moderate late-onset type. The child was no longer hospitalized and was able to attend normal school. Sustained engraftment of male donor liver cells was shown in repeated biopsies, reaching 19% at 8 months and 12.5% at the 12-month follow-up. XXYY tetraploid donor cells were mainly detected during the infusion period (2.5- and 5-month biopsies), whereas in the follow-up 8-month and 1-year biopsies, diploid donor cell subpopulations had become dominant. Moreover, argininosuccinate lyase activity, originally absent, became measurable in 2 different biopsy samples at 8 months, reaching 3% of control activity, indicating in situ metabolic effect and supporting the clinical evolution to a moderate form of the disease. Conclusions: Liver cell transplantation can achieve donor cell engraftment in humans in a significant proportion, leading to sustained metabolic and clinical control with psychomotor catch-up.

Abbreviations used in this paper:  ASA, argininosuccinic acid , ASL, argininosuccinate lyase , CK-7, cytokeratin-7 , FISH, fluorescence in situ hybridization , LCT, liver cell transplantation , OLT, orthotopic liver transplantation

 

 The Liver Cell Transplantation Program is supported by the DGTRE, région wallonne (Grant WALEO/HEPATERA). The Cell Cryopreservation Program is supported by a Grant-Télévie-Fonds National de la Recherche Scientifique.

PII: S0016-5085(06)00009-6

doi:10.1053/j.gastro.2006.01.008

Gastroenterology
Volume 130, Issue 4 , Pages 1317-1323, April 2006